News and Trends 22 Nov 2017 Welsh Scientists Use CRISPR to Engineer Cancer-Killing T cells …cells with their own, which are geared up to better tracking down and killing cancer cells. The research reported in Blood explained how the group removed receptors that interact with… November 22, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jun 2018 French Biotech Develops a New Generation of Safer CAR-T Cells …therapies. The technology, called CubiCAR, makes it easier for CAR-T cells to be detected and purified in the production process. Additionally, it allows CAR-T cells to be killed with the… June 13, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Jun 2024 Eight companies tackling cancer with allogeneic cell therapy in 2024 …therapy: distinguishing cancer cells from normal cells to minimize damage to healthy tissues. The Tmod system involves a two-step process. First, it uses a ‘blocking’ receptor to identify a target… June 13, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 24 Jan 2024 A new chapter in cell therapy: engineered B cells reach the clinic for the first time …and T cells differ in the sense that B cells produce antibodies to attack invading bacteria, viruses, and toxins, while T cells destroy the body’s own cells that have already… January 24, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 20 Jun 2025 Stem cell therapy: a potential cure for hearing loss? …if rare, Drapeau pointed out. And, he added that current stem cell regulations across the globe make it harder for these therapies to hit the market. “The main obstacle to… June 20, 2025 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 15 Sep 2021 Blood Cells: The Future of Drug Delivery …are loaded onto the red blood cells, another solution is used to reseal the cell’s membrane before infusing the cells into the patient. Another company that is working on red… September 15, 2021 - 7 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email
Interview 28 Oct 2020 Do Natural Killer Cells Hold the Key to Treating Blood Cancers? …strains. That’s the ultimate goal of this program.” Just recently, the FDA approved a phase I/II clinical trial that will test the effects of Kiadis’ off-the-shelf NK cell therapy platform… October 28, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
In Depth 3 Jul 2025 Revolutionizing glioblastoma treatment: How CAR-T cell therapy could represent a cure for this deadly brain cancer …CAR-T cells were exposed to it. Not only did this vaccine boost help the engineered CAR-T cells attack tumors, but it also helped to generate host T cells that target… July 3, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 11 Jul 2017 Regenerating the Body With Stem Cells – Hype or Hope? …recently acknowledged that it took about $1.5M and 6 months to treat each patient. It’s a great idea but it’s still got some way to go before it reaches the… July 11, 2017 - 9 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Startup Scout 23 Nov 2018 This Biotech Arms Tumor-Busting Cells to Treat Cancer …antibodies that recruit innate immune cells near tumors and activate them to kill cancer cells. T cells are immune cells that have a strong potential for use in cancer immunotherapies,… November 23, 2018 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Sponsored by Eppendorf 26 Aug 2021 Stem Cell-based Cultured Meat: No Longer Science Fiction …of the first type of stem cells, totipotent cells, that possess the ability to be programmed into any cell type, including embryonic and placental cells. Second are the pluripotent cells,… August 26, 2021 - 7 minutesmins - By Sudha Sundaram Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jan 2024 Ten NK cell therapy companies to look out for this year …that intend to treat AML, multiple myeloma, pancreatic, ovarian, and triple negative breast cancer. Last year, the biotech was awarded a patent for CISH knockout (KO) in NK cells, which… January 11, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email